Thurston Springer Miller Herd & Titak’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$717K Buy
9,166
+899
+11% +$72.5K 0.26% 104
2026
Q1
$716K Sell
8,267
-1,306
-14% -$125K 0.3% 90
2025
Q4
$920K Buy
9,573
+7,661
+401% +$744K 0.32% 77
2025
Q3
$182K Sell
1,912
-24,193
-93% -$2.22M 0.36% 83
2025
Q2
$2.28M Buy
26,105
+3,977
+18% +$337K 0.29% 91
2025
Q1
$1.99M Buy
22,128
+5,737
+35% +$513K 0.33% 85
2024
Q4
$1.31M Buy
16,391
+4,212
+35% +$365K 0.26% 95
2024
Q3
$1.1M Buy
12,179
+1,903
+19% +$160K 0.3% 87
2024
Q2
$809K Buy
+10,276
New +$842K 0.25% 100

Other funds holding MDT

Thurston Springer Miller Herd & Titak's MDT Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Medtronic (MDT) stake by 11% in Q2 2026, buying an estimated $72.5K and bringing the position to 9,166 shares worth $717K. The position accounts for 0.26% of the portfolio, ranked #104.

Thurston Springer Miller Herd & Titak first reported a position in MDT in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.28M in Q2 2025. 795 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 9,166 shares of Medtronic worth $717K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 899 Medtronic shares in Q2 2026, an estimated $72.5K.
  • Medtronic made up 0.26% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #104 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Medtronic in Q2 2024 and has held it in 9 quarters since.
  • Thurston Springer Miller Herd & Titak's Medtronic position peaked at $2.28M in Q2 2025.
  • 795 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.